Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	404.11	205.12	40.69
Graham Fair Price	-55.43	0.60	1.34
PEG	676.33	0.13	-0.02
Price/Book	-50.56	0.55	1.12
Price/Cash Flow	-61.77	14.58	38.15
Prices/Earnings	144.54	-15.65	6.40
Price/Sales	-60.79	6.84	17.45
Price/FCF	-61.77	14.58	38.15
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-21.60	0.33	0.43
Operating Margin	-1.31	-0.07	-0.07
ROA	-79.56	< 0.005	0.02
ROE	0.04	< 0.005	-79.78
ROIC	< 0.005	< 0.005	-93.93
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.02	-0.02	-60.38
Dividends QOQ	-0.45	0.26	-42.66
EBIT QOQ	0.76	-0.27	-65.17
EPS QOQ	3.81	-1.20	-68.50
FCF QOQ	0.84	0.28	-66.45
Revenue QOQ	-0.15	0.25	69.47
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1641.20	1083.46	-33.98
Days Sales Outstanding (DSO)	21.93	140.64	541.37
Inventory Turnover	0.05	0.08	51.48
Debt/Capitalization	0.56	0.55	-0.72
Quick Ratio	0.06	0.23	260.91
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.35	1.37	1.37
Cash	0.04	-1.54	3711.20
Capex	< 0.005	< 0.005	60.51
Free Cash Flow	0.04	0.05	28.17
Revenue	0.09	0.11	24.98
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.17	1.12	-4.32
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	21.32	140.96	561.01
Naive Interpretation	Member

06 - Financial Health · Bad

Rating